Erratum: Protective effects of extract of Ginkgo biloba (EGb 761) on nerve cells after spinal cord injury in rats (Spinal Cord (2006) 44 (662-667) DOI:10.1038/sj.sc.3101900);Protective effects of extract of Ginkgo biloba (EGb 761) on nerve cells after spinal cord injury in rats

Spinal Cord

Volumn 44, Issue 11, 2006, Pages 662-667

  Ao, Q ^a   Sun, X H ^b   Wang, A J ^a   Fu, P F ^c   Gong, K ^a   Zuo, H Z ^a   Gong, Y D ^a   Zhang, X F ^a  

^a TSINGHUA UNIVERSITY   (China)

^b DALIAN MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

Apoptosis; Ginkgo biloba; Inducible nitric oxide synthase; Nerve cells; Spinal cord injuries

Indexed keywords

GINKGO BILOBA EXTRACT; MYELIN; NITRIC OXIDE SYNTHASE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DEMYELINATION; EXPERIMENTAL MODEL; FEMALE; IMMUNOHISTOCHEMISTRY; LAMINECTOMY; NEUROPROTECTION; NICK END LABELING; NISSL SUBSTANCE; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL CORD INJURY; SPINAL CORD NERVE CELL; SPINAL CORD VENTRAL HORN; STAINING; THORACIC SPINAL CORD;

EID: 33750861561     PISSN: 13624393     EISSN: 14765624     Source Type: Journal    
DOI: 10.1038/sj.sc.3101965     Document Type: Erratum

References (26)

1. Beattie MS. Inflammation and apoptosis: linked therapeutic targets in spinal cord injury. Trends Mol Med 2004; 10: 580-583.
2. Chen WH, Tzeng SF. Pituitary adenylate cyclase-activating polypeptide prevents cell death in the spinal cord with traumatic injury. Neurosci Lett 2005; 384: 117-121.
3. Fehlings MG, Bracken MB. Summary statement: the Sygen(GM-1 ganglioside) clinical trial in acute spinal cord injury. Spine 2001; 26: S99-S100.
4. Koda M et al. Brain-derived neurotrophic factor suppresses delayed apoptosis of oligodendrocytes after spinal cord injury in rats. J Neurotrauma 2002; 19: 777-785.
5. Li X, Oudega M, Dancausse HA, Levi ADO. The effect of methylprednisolone on caspase-3 activation after rat spinal cord transection. Restor Neurol Neurosci 2000; 17: 203-209.
6. Gaviria M, Privat A, d'Arbigny P, Kamenka JM, Haton H, Ohanna F. Neuroprotective effects of a novel NMDA antagonist, Gacyclidine, after experimental contusive spinal cord injury in adult rats. Brain Res 2000; 874: 200-209.
7. Calapi G et al. Neuroprotective effects of Ginkgo biloba extract in brain ischemia are mediated by inhibition of nitric oxide synthesis. Life Sci 2000; 67: 2673-2683.
8. Oken BS, Storzbach DM, Kaye JA. The efficacy of Ginkgo biloba on cognitive function in Alzheimer's disease. Arch Neurol 1998; 55: 1409-1415.
9. Zimmermann M, Colciaghi F, Cattabeni F, Di LM. Ginkgo biloba extract: From molecular mechanisms to the treatment of Alzheimer's disease. Cell Mol Biol 2002; 48: 613-623.
10. Ahlemeyer B, Krieglstein J. Pharmacological studies supporting the therapeutic use of Ginkgo biloba extract for Alzheimer's disease. Pharmacopsychiatry 2003; 36: S8-S14.
11. Gong QH, Wu Q, Huang XN, Sun AS, Shi JS. Protective effects of Ginkgo biloba leaf extract on aluminum-induced brain dysfunction in rats. Life Sci 2005; 77: 140-148.
12. Luo Y et al. Inhibition of amyloid-beta aggregation and caspase-3 activation by the Ginkgo biloba extract EGb761. PNAS 2002; 99: 12197-12202.
13. Massieu L, Morán J, Christen Y. Effect of Ginkgo biloba (EGb 761) on staurosporine-induced neuronal death and caspase activity in cortical cultured neurons. Brain Res 2004; 1002: 76-85.
14. Maclennan KM, Darlington CL, Smith PF. The CNS effects of Ginkgo biloba extracts and ginkgolide B. Prog Neurobiol 2002; 67: 235-257.
15. Zurita M, Vaquero J, Oya S, Morales C. Effects of dexamethasone on apoptosis-related cell death after spinal cord injury. J Neurosurg 2002; 96(Suppl): 83-89.
16. Liu XZ et al. Neuronal and glial apoptosis after traumatic spinal cord injury. J Neurosci 1997; 17: 5395-5406.
17. Lu J, Ashwell KW, Waite P. Advances in secondary spinal cord injury: role of apoptosis. Spine 2000; 25: 1859-1866.
18. Martin LJ, Chen K, Liu ZP. Adult motor neuron apoptosis is mediated by nitric oxide and Fas death receptor linked by DNA damage and p53 activation. J Neurosci 2005; 25: 6449-6459.
19. Kim DH, Vaccaro AR, Henderson FC, Benzel EC. Molecular biology of cervical myelopathy and spinal cord injury: role of oligodendrocyte apoptosis. Spine J 2003; 3: 510-519.
20. Horiuchi H, Ogata T, Morino T, Chuai M, Yamamoto H. Continuous intrathecal infusion of SB203580, a selective inhibitor of p38 mitogen-activated protein kinase, reduces the damage of hind-limb function after thoracic spinal cord injury in rat. Neurosci Res 2003; 47: 209-217.
21. Waldmeier PC. Prospects for antiapoptotic drug therapy of neurodegenerative diseases. Prog Neuropsychopharmacol Biol Psychiatry 2003; 27: 303-321.
22. Satake K et al. Nitric oxide via macrophage iNOS induces apoptosis following traumatic spinal cord injury. Mol Brain Res 2000; 85: 114-122.
23. Yu YM, Matsuyama Y, Nakashima S, Yanase M, Kiuchi K, Ishiguro N. Effects of MPSS and a potent iNOS inhibitor on traumatic spinal cord injury. Neuroreport 2004; 15: 2103-2107.
24. Christen Y, Maixent JM. What is Ginkgo biloba extract EGb 761? An overview - from molecular biology to clinical medicine. Cell Mol Biol 2002; 48: 601-611.
25. Zhu L, Wu J, Liao H, Gao J, Zhao XN, Zhang Z. Antagonistic effects of extract from leaves of Ginkgo biloba on glutamate neurotoxicity. Zhongguo Yao Li Xue Bao 1997; 18: 344-347.
26. Hsu SH, Chang CJ, Tang CM, Lin FT. In vitro and in vivo effects of Ginkgo biloba extract EGb 761 on seeded Schwann cells within poly(DL-lactic acid-co-glycolic acid) conduits for peripheral nerve regeneration. J Biomater Appl 2004; 19: 163-182.